ODDB.org: Open Drug Database

Swissmedic Registration	69839	Date of registration	28.01.2026
Company name	Janssen-Cilag AG	Revision date
		Valid until	27.01.2031
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Rybrevant SC 1600 mg/10 ml	Injektionslösung	Injection solution (Amivantamabum 1600mg / 10ml)	L01FX18
02	Rybrevant SC 2240 mg/14 ml	Injektionslösung	Injection solution (Amivantamabum 2240mg / 14ml)	L01FX18

2026	©ywesee GmbH